This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kiemeneij, F. Search for Related Content PubMed PubMed Citation Articles by Kiemeneij, F.

Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial

Ferdinand Kiemeneij, MD^*, Patrick W. Serruys, MD, FACC, Carlos Macaya, MD, Wolfgang Rutsch, MD, Guy Heyndrickx, MD, FACC^||, Per Albertsson, MD^¶, Jean Fajadet, MD^#, Victor Legrand, MD^**, Pierre Materne, MD, Jorge Belardi, MD, Ulrich Sigwart, MD, FACC, Antonio Colombo, MD, FACC^||||, Jean-Jacques Goy, MD^¶¶, Clemens M. C. Disco, MSc^##, Marie-Angèle Morel, BSc^## on behalf of the Benestent I Study Group

^* Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands
Erasmus University, Rotterdam, Netherlands
Hospital Clinico San Carlos, Madrid, Spain
Universitätsklinikum Charité, Berlin, Germany
^|| Onze Lieve Vrouw Ziekenhuis, Aalst, Belgium
^¶ Sahlgrenska University Hospital, Göteborg, Sweden
^# Clinique Pasteur, Toulouse, France
^** CHU Sart Tilman, Liège, Belgium
CHR Hôpital de la Citadelle, Liège, Belgium
Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina
Royal Brompton & National Heart Hospital, London, United Kingdom
^|||| Centro Cuore Columbus, Milan, Italy
^¶¶ Centre Hospitalier Universitaire, Lausanne, Switzerland
^## Cardialysis, Rotterdam, Netherlands

View larger version (30K): [in a new window]   Figure 1 Five-year event-free survival of patients enrolled in the Benestent-I trial. Left upper panel: Kaplan-Meier event-free survival curves for death, cerebrovascular events or myocardial infarction of patients assigned to stenting (dashed line) versus balloon angioplasty (solid line). Right upper panel: Kaplan-Meier event-free curves for any revascularization (CABG and re-PTCA of the target lesion) of patients assigned to stenting (dashed line) versus balloon angioplasty (solid line). Left bottom panel: Kaplan-Meier event-free curves for re-PTCA of the target lesion of patients assigned to stenting (dashed line) versus balloon angioplasty (solid line). Right bottom panel: Kaplan-Meier event-free survival for death, cerebrovascular events, myocardial infarction or any revascularization of patients assigned to stenting (dashed line) versus balloon angioplasty (solid line). CABG = coronary artery bypass grafting; CVA = cerebrovascular accident; FE = Fisher’s exact test; LR = Log Rank test; MI = myocardial infarction; PTCA = percutaneous transluminal coronary angioplasty; RR = relative risk.